(Q33201157)

23 July 2017

Cataract surgery after intravitreal injection of triamcinolone acetonide (English)

1 reference

23 July 2017

Jonas JB

1

1 reference

23 July 2017

Kreissig I

series ordinal

2

1 reference

23 July 2017

Degenring RF

series ordinal

3

1 reference

23 July 2017

1 April 2004

1 reference

23 July 2017

1 reference

23 July 2017

18

1 reference

23 July 2017

4

1 reference

23 July 2017

361-364

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6700654

23 July 2017

0 references

cites work

Exudative macular degeneration and intravitreal triamcinolone. A pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone in recurrence of choroidal neovascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone acetonide for exudative age related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intraocular pressure after intravitreal injection of triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Concentration of intravitreally injected triamcinolone acetonide in aqueous humour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Evaluation of the Retinal Toxicity and Pharmacokinetics of Dexamethasone After Intravitreal Injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

Intravitreal triamcinolone and elevated intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

inferred from DOI database lookup

7 January 2021

based on heuristic

Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

inferred from DOI database lookup

7 January 2021

based on heuristic

The clearance of intravitreal triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700654

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.EYE.6700654

1 reference

Dimensions Publication ID

23 July 2017

0 references

1 reference